CLAG Gleevec in Relapsed or Refractory Acute Myeloid Leukemia (AML)

NCT00955916 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

38

Enrollment

OTHER

Sponsor class

Conditions

Leukemia

Interventions

DRUG: CLAG Regimen
DRUG: Gleevec®

Sponsor

H. Lee Moffitt Cancer Center and Research Institute

Collaborators

[object Object]